2ls7
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
==High Definition Solution Structure of PED/PEA-15 Death Effector Domain== | ==High Definition Solution Structure of PED/PEA-15 Death Effector Domain== | ||
| - | <StructureSection load='2ls7' size='340' side='right' caption='[[2ls7 | + | <StructureSection load='2ls7' size='340' side='right'caption='[[2ls7]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2ls7]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2ls7]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2LS7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2LS7 FirstGlance]. <br> |
| - | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2ls7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2ls7 OCA], [https://pdbe.org/2ls7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2ls7 RCSB], [https://www.ebi.ac.uk/pdbsum/2ls7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2ls7 ProSAT]</span></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/PEA15_MOUSE PEA15_MOUSE] Blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade. Inhibits RPS6KA3 activities by retaining it in the cytoplasm. Inhibits both TNFRSF6- and TNFRSF1A-mediated CASP8 activity and apoptosis. Regulates glucose transport by controlling both the content of SLC2A1 glucose transporters on the plasma membrane and the insulin-dependent trafficking of SLC2A4 from the cell interior to the surface (By similarity). |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 23: | Line 22: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Mus musculus]] |
| - | [[Category: | + | [[Category: Twomey EC]] |
| - | [[Category: | + | [[Category: Wei Y]] |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
High Definition Solution Structure of PED/PEA-15 Death Effector Domain
| |||||||||||
